secwatch.observer — SEC 8-K summary
======================================

Issuer:     biote Corp. (BTMD)
CIK:        0001819253
Form:       8-K
Filed at:   2025-05-07T23:59:59+00:00
Accession:  0000950170-25-065638
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 2.05, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biote Q1 net income $15.8M vs loss, revenue $49.0M, restructuring 16 employees
------------------------------------------------------------------------------

- Net income of $15.8M ($0.37 diluted EPS) vs net loss of $(5.7M) ($(0.12) per share) in Q1 2024.
- Revenue $49.0M, up 4.7% YoY; dietary supplements +25.5%, procedure revenue -3.6%.
- Adjusted EBITDA $13.8M (28.1% margin); gross profit margin 74.3% from vertical integration.
- Board authorized restructuring on May 1, cutting 16 employees; completed May 5; charges $0.6-0.8M.
- Company maintains 2025 financial outlook.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819253/000095017025065638/0000950170-25-065638-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819253/000095017025065638/btmd-20250501.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-065638

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer